February 3, 2026
1 min read

India will invest $1.1B to boost development of biologics, biosimilars

Long known for manufacturing generics, vaccines and small-molecule drugs, India is attempting to shift its focus, with a big boost from its government. The country will invest 100 billion rupees ($1.1 billion) over the next five years to increase research and production of biologics and biosimilars

Leave a Reply

Your email address will not be published.

Previous Story

NASA’s Crew-12 Begins Quarantine Before February Launch to Space Station MedNews

Next Story

Baby Formula Pulled in Europe After New Safety Limits on Harmful Toxin MedNews

Previous Story

NASA’s Crew-12 Begins Quarantine Before February Launch to Space Station MedNews

Next Story

Baby Formula Pulled in Europe After New Safety Limits on Harmful Toxin MedNews

Latest from Blog

Go toTop